ArticleOrganic letters2026
Unactivated Photoredox C-H Amination with Diazirines: Access to Acyldiaziridines.
Article in Organic letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
A metal-free, photoinduced amination of unactivated C-H bonds from abundant, simple alkanes with diazirines is reported. The transformation provides diversifiable diaziridine products (40 examples) in up to 95% yields. The conditions are suitable for four different classes of C-H bonds, including aldehydes, which results in the formation of previously unavailable acyldiaziridines. This class of molecules is shown to consist of versatile precursors that are easily converted into amides, hydrazides, acyl hydrazones, and heterocycles.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.